Physician
Stamp, Jeffrey
Stamp, Jeffrey was paid $74K by Medicaid between Jan 2018 and May 2024, across 6 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 66% of everything it billed.
33Billing provider infoSTAMP, JEFFREY
CABOT, AR 72023
CABOT, AR 72023
33aNPI1023079985assigned 03/30/2006
33bProvider typeFamily Medicine Physician
28Total paid$74K
24GClaims2,141
24DCodes billed6
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Family Medicine Physician providers in Arkansas
Rank by total paid#216 of 437
Median peer was paid$70K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 458 | $16K | |
| 2019 | 425 | $14K | |
| 2020 | 275 | $9K | |
| 2021 | 600 | $22K | |
| 2022 | 366 | $13K | |
| 2024incomplete | 17 | $742.90 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 66% | 1,590 | 1,435 | $48K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 376 | 342 | $22K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 12 | 12 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 94 | 44 | $946.20 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.0% | 22 | 22 | $768.91 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 47 | 44 | $592.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.